PMV
PMV Do and dare company
mute

PMV is a do and dare company that is shaping the future of the Flemish economy.

PMV provides finance for promising businesses, from their very start, through their various growth stages and even on to operating internationally.

Working with and for the government and other partners, PMV implements projects that are important for prosperity and wellbeing in Flanders.

PMV coordinates the investment funds of the European Fund for Strategic Investments (EFSI) in Flanders

PMV is the contact point for every enquire for the Juncker Plan, officially the "European Fund for Strategic Investments" (EFSI).

More info

News

16
/06

Aphea.Bio aims at leading position in next generation agricultural biologicals New VIB spin-off launches with 9 million euros in funding

VIB, Ghent University and KU Leuven have launched a new spin-off: Aphea.Bio. This new company will develop sustainable agricultural products based on natural microorganisms to increase crop yields and to protect them against specific fungal diseases. Thanks to a successful Series A financing round and an R&D grant approved by Flanders Innovation & Entrepreneurship (VLAIO), Aphea.Bio is now backed by 9 million euros of funding, giving it a clear shot at a leading position in the fast-emerging market of biopesticides and biostimulants. Headquartered in Ghent , Belgium, Aphea.Bio will be led by CEO Dr. Isabel Vercauteren and CSO Dr. Steven Vandenabeele.

portfolio

Amakem

Amakem
Testimonial: 
Amakem is een Limburgs farmabedrijf dat innovatieve behandelingen ontwikkelt tegen oogziektes. Hun belangrijkste programma is het onderzoek van kinase-inhibitoren, of middelen die eiwitten helpen hun werk als antistoffen beter te doen.

Q-Biologicals

Q-Biologicals
Testimonial: 
Q-Biologicals is een Gents biopharmabedrijf dat een breed gamma diensten aanbiedt in procesontwikkeling en biomanufacturing.

Multiplicom

Multiplicom
Testimonial: 
Multiplicom is specialist in moleculaire diagnostiek om te bepalen of iemand een verhoogd risico heeft om een ziekte te ontwikkelen, om genetische defecten op te sporen en om dokters effectieve medicijnen te laten voorschrijven.

Apitope

Apitope
Testimonial: 
Apitope is een Europees biotechbedrijf gericht op het onderzoek en ontwikkeling van revolutionaire ziektetherapie├źn voor auto-immuunziekten en allergie├źn, zoals multiple sclerose, de ziekte van Graves en Factor VIII.